Moderna (MRNA) Reports In-Line Q1 EPS

Moderna (NASDAQ: MRNA) reported Q1 EPS of ($0.35), in-line with the analyst estimate of ($0.35). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $17.09 million.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• LTC Properties (LTC) PT Raised to $52 at RBC Capital
• Moderna (MRNA) call put ratio 1 call to 1.1 puts amid wide price movement